CAPTRUST Financial Advisors’s Adaptimmune Therapeutics ADAP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $19K | Sell |
79,083
-1,526
| -2% | -$366 | ﹤0.01% | 2471 |
|
|
2025
Q1 | $15.9K | Sell |
80,609
-1,020
| -1% | -$201 | ﹤0.01% | 2325 |
|
|
2024
Q4 | $44K | Sell |
81,629
-1,412
| -2% | -$761 | ﹤0.01% | 2247 |
|
|
2024
Q3 | $78.9K | Hold |
83,041
| – | – | ﹤0.01% | 2214 |
|
|
2024
Q2 | $81K | Sell |
83,041
-28,911
| -26% | -$28.2K | ﹤0.01% | 2125 |
|
|
2024
Q1 | $177K | Buy |
111,952
+94,698
| +549% | +$150K | ﹤0.01% | 2009 |
|
|
2023
Q4 | $13.7K | Sell |
17,254
-4,670
| -21% | -$3.7K | ﹤0.01% | 2630 |
|
|
2023
Q3 | $17.1K | Hold |
21,924
| – | – | ﹤0.01% | 2526 |
|
|
2023
Q2 | $20.3K | Buy |
21,924
+302
| +1% | +$279 | ﹤0.01% | 2461 |
|
|
2023
Q1 | $23.6K | Buy |
+21,622
| New | +$23.6K | ﹤0.01% | 2243 |
|
|
2022
Q4 | – | Sell |
-19,622
| Closed | -$21K | – | 2054 |
|
|
2022
Q3 | $21K | Buy |
19,622
+15,000
| +325% | +$16.1K | ﹤0.01% | 2015 |
|
|
2022
Q2 | $8K | Hold |
4,622
| – | – | ﹤0.01% | 3853 |
|
|
2022
Q1 | $10K | Buy |
4,622
+3,682
| +392% | +$7.97K | ﹤0.01% | 3786 |
|
|
2021
Q4 | $4K | Hold |
940
| – | – | ﹤0.01% | 4153 |
|
|
2021
Q3 | $5K | Hold |
940
| – | – | ﹤0.01% | 3926 |
|
|
2021
Q2 | $4K | Hold |
940
| – | – | ﹤0.01% | 3924 |
|
|
2021
Q1 | $5K | Buy |
+940
| New | +$5K | ﹤0.01% | 3707 |
|